Stay updated with breaking news from Antiviral Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration...
BOSTON, May 18, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today
/PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration...
By Riley Griffin & Josh Wingrove In its quest to build up its stockpile of Covid-19 drugs, the US government has held talks with Japanese drugmaker Shionogi & Co. about buying its experimental antiviral pill, people familiar with the matter said. Finding the money to pay for it could be…
Shionogi's treatment is in late-stage clinical trials and hasn’t yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.